|
|
|
|
|
|
|
Poster: 250
Visits: 66
Title: The mTORC1 Inhibitor Everolimus Produces Tumor Responses in Patients with Relapsed T-cell Non-Hodgkin Lymphoma
Authors: Thomas Witzig , Craig Reeder et al
Centre: Mayo Clinic
|
|
You must be registered to reply or comment.
|
|
THE MTORC1 INHIBITOR EVEROLIMUS PRODUCES TUMOR RESPONSES IN PATIENTS WITH RELAPSED T-CELL NON-HODGKIN LYMPHOMA
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 231
Visits: 186
Title: Clinical Characteristics and Patterns of Care of Patients (pts) with Peripheral T-cell Lymphoma (PTCLs) according to age at time of diagnosis: A T-Cell Project snapshot.
Authors: Monica Bellei , Marcheselli, Pesce, Horwitz, Vose, Montoto, Pileri, Ko, Zucca, Foss, Connors, Polliack, Zinzani, Advani, Cabrera, De Souza, Kim, Martinez, Merli, Moskowitz, Nagler, Radford, Shustov, Spina, Federico
Centre: T-Cell Project Network
|
|
|
|